Independent Editorial Rankings
We independently rank GLP-1 telehealth providers, weight loss programs, and the pharmacies behind them — so you can save money without falling for sketchy ads.
Reader-supported. When you sign up with a provider through our links we may earn a commission at no extra cost to you. How we make money.
Why readers use us
Brand-name Wegovy retails for around $1,349/month without insurance. The median compounded semaglutide provider in our dataset charges $179/month— same active ingredient, same weekly injection, a fraction of the cost.
Cheapest first-month rate currently in our dataset: $49/mo. Introductory pricing varies by provider and typically increases after the first month — always verify on the provider's site before signing up.
Quick Match
Three questions. We'll instantly show you the highest-rated provider that matches your budget, state, and preference — based on real pricing data.
Featured Partners
Best for men seeking compounded GLP-1 alongside testosterone optimization
“All 50 states + DC coverage”
Best for Brand-name GLP-1s at cash prices, no compounding
Best for the lowest flat medication price if you can absorb an annual membership fee
Every provider in our dataset has a first-party editorial review with a six-dimension score, verified pricing, state coverage, and primary-source citations. Read what we found before signing up.
Use our savings calculator to see what you could pay — then compare providers side by side to find the best deal.
Interactive pharmacokinetic simulator showing how semaglutide, tirzepatide, and Foundayo (orforglipron) build up across the standard FDA titration schedule.
6-drug interactive timeline showing when nausea peaks, when it resolves, and what every other GLP-1 side effect looks like by week. Every cell anchored to a primary source.
Coverage Map
Click any state to see the providers that ship and prescribe there. Darker squares mean more provider options available.
Coverage data compiled from 637 GLP-1 telehealth providers tracked by Weight Loss Rankings.
Editorial flagship
Primary-source deep-dives on GLP-1 weight-loss medications, every claim cited from FDA prescribing information and PubMed.
What causes gestational diabetes, how pre-pregnancy BMI and weight change between pregnancies affect risk, why treatment matters, the later type 2 diabetes risk and how to lower it, and what is known about stopping GLP-1 drugs before pregnancy.
Read the analysis→What xanthelasma (yellow cholesterol deposits around the eyes) says about cholesterol and heart risk, whether body weight plays a role, what weight loss and GLP-1 drugs do to LDL, and how removal options compare.
Read the analysis→What causes heat rash (miliaria), why it can lower heat tolerance for weeks, and how body weight, skin folds and heat load fit in. What the evidence shows about treatment and prevention, and the gaps on weight loss and GLP-1 drugs.
Read the analysis→A clinician-informed 7-day plan, protein & fiber targets, food lists, and a grocery list — sent straight to your inbox.